Menu
Urology and urogynecology practices in 2025 are understandably exhausted by yet another price increase to their urodynamics catheters. Over the past six years, our competitor has increased the average price of a urodynamic study from $90.66 to $208.28 representing a 153% change that practices need to absorb.
We’ve had many discussions with urologists and urogynecologists who are frustrated and looking to regain some level of control over the costs their practices are facing. Gemini was founded because of similar frustrations and aims to be a better partner to practices.
By switching to Gemini’s Atmos air-charged urodynamic catheters, urology and urogynecology practices have had consistent prices and are saving nearly $98 each time they perform a urodynamic study.
While pricing matters are important, we understand it isn’t the only factor that urologists and urogynecologists consider when choosing their suppliers. We understand practices need consumables that deliver reliable and accurate data. That’s why, before launching Atmos, we conducted a comprehensive validity study to ensure that they provide reliably accurate pressure measurements.
Urologists and urogynecologists also deserve a trustworthy partner, not just a supplier. We take pride in listening to the goals and challenges your practice is facing and working together to address them. This goes beyond the conversations around air-charged urodynamic catheters and has motivated us to bring new options to the equipment market, including urodynamic systems, uroflowmeters, bladder scanners, and more.
We’ll set up a time to go over what catheters your practice is currently using and estimate the savings you can get by switching to Gemini.